Ann: US nursing home study to pave way for FDA De Novo clearance, page-18

I don't remember putting any price target at all. Just expecting the company to become at least revenue neutral by then. And after that, for those who owns plenty of this stock, the dividend income should be enough to support a very comfortable retired lifestyle. And if that comes to pass, then naturally, the share price would take care of itself.

And this is why I keep saying at current share price, it is truly an opportunity of a life time. If all goes to plan, I expect by 2025, the share price will bag a few times current price. Once the market wakes up to this (especially once they get FDA approval), there will be no stopping this hot speed train.